Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)

Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	758,957	1,038,982	1,087,244	976,101	1,048,678	486,740
Market Cap Growth	-30.91%	-4.44%	11.39%	-6.92%	115.45%	166.35%
Enterprise Value	781,705	1,031,571	1,069,527	969,321	1,050,097	491,980
Last Close Price	19060.00	26100.00	27400.00	25250.00	29200.00	14050.00
PE Ratio	-	-71.51	-68.16	-46.49	-126.96	434.04
PS Ratio	82.28	109.58	138.47	105.62	83.82	16.18
PB Ratio	15.33	22.95	18.67	15.85	20.04	10.19
P/FCF Ratio	-220.06	-158.67	-60.11	-227.78	-59.24	79.62
P/OCF Ratio	-229.03	-172.92	-65.72	-1812.71	139.79	53.03
EV/Sales Ratio	84.60	108.80	136.22	104.89	83.93	16.35
EV/EBITDA Ratio	-100.51	-123.26	-43.60	-147.18	-1609.84	78.93
EV/EBIT Ratio	-88.32	-105.22	-40.65	-104.35	-237.04	203.31
EV/FCF Ratio	-235.17	-157.54	-59.13	-226.20	-59.32	80.47
Debt / Equity Ratio	0.61	0.12	0.11	0.25	0.71	0.28
Debt / EBITDA Ratio	-	-	-	-	-	2.16
Debt / FCF Ratio	-11.02	-0.85	-0.35	-3.61	-2.10	2.20
Asset Turnover	0.11	0.16	0.11	0.11	0.16	0.51
Inventory Turnover	3.78	1.62	1.63	1.59	1.19	3.23
Quick Ratio	0.62	1.77	2.23	1.73	3.41	1.77
Current Ratio	0.72	2.18	2.67	2.02	4.37	2.29
Return on Equity (ROE)	-23.15%	-28.02%	-26.39%	-35.21%	-16.50%	3.56%
Return on Assets (ROA)	-6.18%	-10.20%	-22.24%	-6.66%	-3.51%	2.56%
Return on Capital (ROIC)	-6.57%	-10.63%	-23.24%	-6.97%	-3.67%	2.73%
Earnings Yield	-0.87%	-1.40%	-1.45%	-2.05%	-0.79%	0.23%
FCF Yield	-0.44%	-0.63%	-1.66%	-0.44%	-1.69%	1.26%
Buyback Yield / Dilution	-0.52%	-1.04%	-6.64%	-2.79%	-3.67%	-2.75%
Total Shareholder Return	-0.52%	-1.04%	-6.64%	-2.79%	-3.67%	-2.75%

Source: S&P Capital IQ. Standard template. Financial Sources.